Advertisement
Advertisement
IDXX
Idexx Laboratories Inc
556.97
USDSponsored
+0.04
+0.01%
Aug 24, 11:17 UTC -4
Open
IDXX Earnings Reports
Positive Surprise Ratio
IDXX beat 40 of 42 last estimates.
95%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.21B
/$3.82
Implied change from Q2 26 (Revenue/ EPS)
-0.15%
/-10.33%
Implied change from Q3 25 (Revenue/ EPS)
+9.90%
/+12.35%
Idexx Laboratories Inc earnings per share and revenue
On Aug 04, 2026, IDXX reported earnings of 4.26 USD per share (EPS) for Q2 26, beating the estimate of 4.02 USD, resulting in a 6.21% surprise. Revenue reached 1.22 billion, compared to an expected 1.22 billion, with a -0.66% difference. The market reacted with a +3.57% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of 3.82 USD, with revenue projected to reach 1.21 billion USD, implying an decrease of -10.33% EPS, and decrease of -0.15% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neuronetics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+60.00%
Stereotaxis, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
LENSAR, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.16
Actual
$0.10
Surprise
+159.42%
DarioHealth Corp. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$1.23
Actual
-$0.56
Surprise
+54.01%
Sensus Healthcare, Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.18
Surprise
-41.18%
QT Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.19
Surprise
+15.06%
Accuray Incorporated
Report Date
Aug 19, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.02
Surprise
+80.39%
American Shared Hospital Services
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.07
Surprise
-246.53%
ENvue Medical, Inc. Common Stock
Report Date
Aug 17, 2026 For Q2 26
Estimate
-Actual
-$1.98
Surprise
-
Nuwellis, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.69
Actual
-$26.64
Surprise
-3,740.83%
FAQ
What were Idexx Laboratories Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Idexx Laboratories Inc reported EPS of $4.26, beating estimates by 6.21%, and revenue of $1.22B, -0.66% below expectations.
How did the market react to Idexx Laboratories Inc's Q2 2026 earnings?
The stock price moved up 3.57%, changed from $567.84 before the earnings release to $588.09 the day after.
When is Idexx Laboratories Inc expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Idexx Laboratories Inc's next earnings report?
Based on 11
analysts, Idexx Laboratories Inc is expected to report EPS of $3.82 and revenue of $1.21B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement